[1]
Zuckschwerdt, A. et al. 2026. Pembrolizumab: Comparison Between Fixed Dose and Weight-Based Dose in the Treatment of Non-Small Cell Lung Cancer . Proceedings of Research and Practice in Allied and Environmental Health. 3, 2 (ago. 2026), 32. DOI:https://doi.org/10.26537/prpaeh.v3i2.6127.